MawiDna
Mawi - Biosampling Reinvented
  • OUR PRODUCTS
  • ABOUT US
    • Careers
    • Our Team
    • Our Technology
    • Worldwide Contacts
  • LEARN
    • Articles & Applications
    • DNA/RNA Extraction methods
    • Blog
    • FAQ
  • CONTACT
Request sample kit arrow

News

  • Active Partnerships
  • Press
  • Blog
    • About Mawi DNA Technolgies
    • Announcements
    • Articles & Cohort Studies
    • Biosampling Technology
    • Events
    • Hematology
    • In The Press
    • iSWAB Insights
    • News
    • Uncategorized
  • Blog
  • Announcements

Mawi DNA Technologies Launches iSWAB-Microbiome Sample Collection System

Jan 11, 2017

Mawi DNA Technologies Launches iSWAB-Microbiome Sample Collection System

HAYWARD, CA – January 11, 2017 – Mawi DNA Technologies, a biotechnology company focusing on development of innovative technologies for biosampling, announces the launch of iSWAB-Microbiome (ISWAB-MB) designed to collect and stabilize microbial content and diversity within collected gut, rectal, vaginal, skin, oral or soil samples from collection to processing.

“iSWAB-MB significantly improves on current sampling and transport methods such as freezing or organic solvents. These collection methods can be challenging to use in the field and often result in alterations to the microbiome from time of collection to processing,” said Dr. Bassam El-Fahmawi, President and CTO of Mawi DNA Technologies. He added that offering an accurate snapshot of the microbiome representation at the exact time of collection is critical for a more precise understanding of the relationship between microbiome diversity and human or animal health.

The ISWAB-MB was developed to overcome issues that can affect microbiome research by:

  • Producing an accurate representation of the microbiota composition without loss of any taxa from the point of collection to processing, simplifying bioinformatic analysis by substantially reducing post-collection bias. Samples can be transported and maintained at room temperature up to four weeks (stability testing ongoing);
  • Providing the ability to analyze the microbiome with minimal host gDNA contamination; and
  • Enabling analysis of the microbiome’s DNA and RNA from the same sample, providing more comprehensive knowledge of the microbiome and allowing better correlations for medical research.

“This product would be an ideal match for a project like the National Microbiome Initiative launched in May 2016,” said Jerome David, Vice President at Mawi DNA Technologies. “Our goal is to aggressively pursue these opportunities in 2017 and beyond.”

Samples of the iSWAB-MB product can be requested at www.mawidna.com

Related news

Mar 13, 2025

A Journey of Innovation and Vision – The Mawi Story…...

Mawi was founded with one major goal: to simplify sample collection, transportation, and storage while making the process as painless as possible, especially for babies and the elderly. The collected ...

READ MORE
Oct 13, 2024

Mawi DNA Technologies Partners with GenoBank.io To Tokenize Our Groundbreaking…...

October 14, 2024 – We are thrilled to announce that Mawi DNA Technologies has officially partnered with READ MORE

Oct 09, 2024

Mawi DNA Partners with Tempus AI and Tally Health™ to…...

October 7, 2024 – Customers frequently ask what swabs are compatible with our iSWAB® non-invasive sample collection technology. Although most swab types can be used with our system, incl...

READ MORE

Join our mailing list for updates and news about mawi

      • Our Products
      • FAQ
      • About Us
      • Contact
      • Resources
      • Blog
      • Sitemap

    Mawi DNA Technologies LLC

    1252 Quarry Lane Suite A,
    Pleasanton, CA | 94566

    Telephone: 510-256-5186

    Toll-Free: 855-DNA-SWAB

    LinkedinLinkedin TwitterTwitter YoutubeYoutube

    Copyright © 2024 Mawi DNA Technologies LLC.

    mawi-hemasure-sample mawi-hemasure-sample-new

    Download our free documents